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1. Introduction
The oral squamous cell carcinoma is a particular type of cancer classically described as a
tobacco- and alcohol-related disease affecting mostly elderly male patients. However, epide‐
miologic studies have demonstrated an increasing incidence of young individuals with oral
cancer. Interestingly, the clinicopathological profile, etiology, risk factors, and outcome of
patients with early-onset disease seem to present several differences compared to late-onset
oral carcinoma and these discrepancies are discussed below.
2. Clinical manifestations
Retrospective studies including elderly and young patients have shown that the incidence of
squamous cell carcinoma (SCC) of the mouth in young people is low but presents an increasing
tendency [1]. In fact, there is certain heterogeneity of the cutoff age employed in the studies.
Most authors consider young patients as those who are under 40 or 45 years [2-6] whereas few
investigations select individuals under 20 or 30 years [7-9]. The incidence of oral cancer in
patients younger than 40 years of age varies between 0.4–3.6%, but it can reach 6.7% in studies
considering 45 years as the cutoff point [10]. Due to its rarity, most investigations deal with a
small sample of patients, and conflicting results have been published regarding the epide‐
miological aspects of oral SCC.
The clear male predominance found in late-onset lesions is not found in the early-onset
counterparts. Men are still more affected than women but only slightly more, with a F:M ratio
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varying from 1:1.2 to 1:4.9 [11, 12]. These data show an evident augmentation in the number
of young women affected by oral SCC. The differences between sex distribution previously
observed may be due to smoking and drinking habits, which are more socially acceptable for
both genders currently [10].
The most common oral subsite for SCC in young patients is the tongue, with 39–77% of the
cases [13, 14]. A study conducted in Taiwan found a higher incidence of oral SCC in the buccal
area (53.6%) in comparison with the tongue (42, 8%), but betel chewing was common among
these patients [15]. Other retrospective reports in Germany and Brazil showed a slightly higher
incidence of oral SCC in the floor of the mouth, followed by the mobile tongue [12, 16].
The typical clinical appearance of oral SCC in young patients is an ulcer, often intermixed with
white plaque and/or reddish areas. Kuriakose et al. [17] noted that lesions in young patients
were predominantly invasive as compared with the exophytic lesions found in older patients
[10, 17]. On the other hand, Falaki et al. [18] reported exophytic lesion with ulcer as the most
common clinical presentation in younger individuals.
Figures 1 and 2 illustrate a 35-year-old young man who presented with a white plaque
intermixed with erythroplastic areas in the right border of the tongue. The duration of the
lesion was of one year, and the patient reported slight pain. Moreover, the individual did
neither consume tobacco nor alcohol. Incisional biopsy confirmed the diagnosis of SCC that
was staged lately as T2N0M0. The patient was submitted to partial glossectomy with supra‐
omohyoid selective neck dissection of the same side and radiotherapy. The one-year follow-
up was uneventful.
Figure 1. Clinical features of oral SCC in young patient – presence of white plaque and ulceration at the right lateral
surface of the mobile tongue of a 35-year-old patient.
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Figure 2. Arrows indicate the lesion showed in Figure 1. Elevated and indurated borders were confirmed by palpation,
demonstrating the infiltrative growth of the tumor.
Regarding the symptoms, initial local pain is uncommon [19]. Other signs and symptoms can
be dysphagia, weight loss and otalgia (26.5%, 26.6% and 37.5%, respectively) [20], but they
seem to be related to the size and anatomic location of the tumor. The duration of the symptoms
before diagnosis can vary, but reported data show that most of the patients had early stage
disease at the moment of diagnosis, that is, from 52-95% of the patients presented with lesions
graded as T1 or T2, usually without neck metastasis [13, 21]. Fang et al. [22] reported that 80%
of patients younger than 40 years-old with oral SCC presented lesions staged as T1 or T2 and
only one tumor with positive node metastasis, appearing to be weakly aggressive at diagnosis.
However, the clinical result was poor, as 10 (66.7%) patients exhibited recurrence and five
(33%) patients succumbed to the disease [22].
The delay before diagnosis is usually between few weeks and 10 months [23, 24].
3. Microscopic findings
The microscopic features that define an oral SCC do not differ between young and old patients.
SCC is an invasive epithelial neoplasm with varying degrees of squamous differentiation.
Disorganized stratified squamous epithelium forming strands and islands of bizarre epithelial
cells presenting severe dysplasia infiltrating subjacent submucosa is observed. Dyskeratosis,
polymorphism, hyperchromatism, atypical mitosis and loss of nucleolus-nucleus and nucleus-
cytoplasm ratio are also marked cellular characteristics [25], as shown in Figures 3 and 4.
The tumors are traditionally graded into well, moderately, and poorly differentiated SCC.
According to the World Health Organization (WHO), well-differentiated carcinoma resembles
closely normal squamous epithelium. Moderately differentiated carcinoma contains distinct
nuclear pleomorphism and mitotic activity, including abnormal mitosis, and there is normally
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less keratinization. In poorly differentiated carcinoma, immature cells predominate, with
numerous typical and atypical mitosis, and minimal keratinization. Most of the SCCs are
moderately differentiated [25]. The studies in young population also showed a higher
incidence of moderately differentiated oral tumors, ranging from 40.9% to 70% of the sample
[7, 20, 26-29]. Hilly et al. [8] and Garavello et al. [27] found worse prognosis and higher indexes
of moderately and poor differentiated tumors in their sample. Controversially, Hyam et al. [30]
found similar prognosis associated with 67% of poorly differentiated tumors. Grading by
differentiation is of limited prognostic value, as compared to the pattern of invasion [25].
Figure 3. Neoplastic squamous epithelium infiltrating subjacent submucosa (H&E original magnification X50).
Figure 4. Detail of neoplastic epithelial cells with atypical mitotic figures, dyskeratosis, and loss of nucleolus-nucleus
and nucleus-cytoplasm ratio; neoplastic cells presenting polymorphism and hyperchromatism (H&E original magnifi‐
cation X400).
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4. Etiology/risk factors
4.1. Tobacco and alcohol
In  recent  years,  an  increasing  number  of  young  patients,  who  declare  to  never  having
smoked or consumed alcohol excessively, are diagnosed with oral SCC [17, 31]. Tobacco
smoke and alcohol abuse are considered well-established risk factors for oral SCC in older
population. Otherwise, in young patients, these classical risk factors cannot be considered
as the major ones for oral cancer [10, 17, 32, 33], if the period of abuse is not enough to
create carcinogenesis [10].
On the  other  side,  some studies  report  that  tobacco  use  starts  during  adolescence  [10],
usually before 16 years old, making probable that before the age of 40 years, patients have
an accumulated risk of more than 21 years of consumption, being more susceptible for the
oral cancer [34].
Probably, the pathogenesis of oral SCC in young people involves multiple factors, as genetic
and others new behavioral factors [32, 33]. It seems that tobacco and alcohol consumption are
not the main etiological factors for oral SCC in young patients.
4.2. Genetic factors
Genetic predisposition for cancer development at young age, especially in those patients with
no recognized risk factors seems to be preponderant [34]. Chromosome fragility, DNA ploidy
abnormalities and increased familial risk of head and neck SCC have already been reported
in young patients [26, 34, 35].
Considering the familial risk, a clear significant relative risk of SCC exists in first-degree family
members of those who suffered head and neck cancer [35], especially when there is no
recognized risk factor associated. Oral cancer has been associated with higher chromosome
fragility and instability in youngsters, compared to elderly [36].
Genetic instability is an important molecular mechanism for head and neck cancers [35]. Gain
and loss of specific chromosome regions in DNA are responsible for head and neck cancers,
for example the 3p or 9p21 region, which are early events strictly related with head and neck
cancer development, but that are not commonly seen in young people [35]. It is supposed that
a completely different model of tumorigenesis exists, at a molecular level, in young people.
One essential step for tumorigenesis is deregulation of normal cell cycle regulatory system,
especially in genes that control G1 to 2 phase progression in cell cycle [37]. The amplification
of the gene CCDN1 was noted to be more expressive in young people [31]. CCDN1 is a proto-
oncogene that encodes cyclin D1, a key regulator of G1 phase in cell cycle. The overexpression
of cyclin D1 was found to be more prominent in young people [31], and it was correlated with
disease-free survival in younger and elderly patients. Instead of these findings, larger studies
are required to confirm the prognostic value of CCDN1 in young patients.
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4.3. Behavioral and other factors
4.3.1. Marijuana consumption
Several cases reported in the literature [38, 39] suggest an association between marijuana
smoking and head and neck cancers and respiratory cancers, but this correlation is not
conclusive.
The use of marijuana has been speculated as a risk factor for oral cancer in young people [10].
The main reason is that marijuana smoke contains carcinogens similar to those in tobacco, and
marijuana smoking involves greater inhalation and longer retention of marijuana smoke [34].
However, the potential of carcinogenicity of tetrahydrocannabiol (THC), the major psychoac‐
tive ingredient in marijuana, is not clear yet [40], but it is evident that cannabinoids have an
effect in tumorigenic or antitumorigenic role [41]. The patient with oral SCC illustrated in the
Figures 1 and 2 confirmed frequent marijuana use when he was a teenager.
4.3.2. Immunodeficiencies
Some chronic immunodeficiency states (Bloom syndrome, Wiskott-Aldrich syndrome), or
even immunosuppression regimes following organ transplantation [34] and anemia (Patterson
Kelly/ Plummer Vinson syndrome, Fanconi anemia) [35], might play important roles in
carcinogenesis in young people. Specifically, Fanconi anemia has an associated higher risk for
developing head and neck cancer, estimated to be 40% by the fourth to sixth decade of life.
Mutations in telomerase complex are responsible for Fanconi anemia and regarding its
malignant transformation, telomeres are repeatedly shortened precipitating a genetic insta‐
bility, allowing the progression to a malignant neoplasia [35].
Another distinct group that compound young head and neck cancer patients is those with
cancer during childhood. The probability of a second synchronous tumor or metachronous
primary tumor is estimated in 3–12% in 20 years of survival. Also, chemotherapeutic drugs
and radiation can induce malignancies as side effects [7, 42].
4.3.3. Diet
A well-defined concept is that a diet rich in fruits and vegetables, with antioxidant properties,
has a protective role against oral cancer [43]. A significant reduction in the risk of oral SCC
was found among females consuming three or more portions of fresh fruits and vegetables
daily [43, 44]. However, this factor is preponderant for the population in general and there are
no studies on specific dietary behavior for young people.
4.3.4. Viral infections
The human papillomavirus (HPV) comprises a huge group of more than 50 subtypes of viruses
able to infect the anogenital region and can be divided into two major subgroups: low-risk and
high-risk types for cancer [45]. The low-risk HPVs are usually responsible for genital warts
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that rarely progress into malignancy whereas the high-risk ones have oncogenic capability,
leading to the development of cancer. The HPV-16 and HPV-18 are the major high-risk types
that are present in anogenital and head and neck cancers [45].
Recent changes in the epidemiological profile of oral carcinoma have encouraged the research
for new risk factors related to the development of oral cancer. For example, there has been a
decrease in the tobacco-associated oral cancer and an increase of non-smoking white female
young patients (18–44 years) who presented with oral SCC [46]. These facts, associated with
the established oncogenic power of HPV-16 in cervix carcinoma [47] raised the hypothesis that
HPV could be an etiological factor for oral SCC. Moreover, oral mucosa is highly exposed to
chemical carcinogens, infections, and trauma, making it more vulnerable to carcinogenesis.
Then, it has been postulated that abrasions caused due to this continuous exposure might make
this mucosal surface more susceptible to HPV by making it easier for the virus to gain entry
into the basal cells of oral mucosa [45].
The mechanism by which the high-risk HPVs promote the carcinogenesis has been already
revealed. Once the cell is infected with HPV, the viral oncoproteins E6 and E7 are integrated
to the cell genome and their expressions alter the host genome functions [45, 46]. HPV E6 and
E7 proteins disrupt p53 and pRb tumor suppressor genes as well as numerous cellular proteins
involved in carcinogenesis (BAK, telomerase, INK4A, E2F, cyclins A and E, WAF1, and KIP1)
[46]. These accumulated defects in the genomic expression of the infected cells lead to cell
immortalization and genomic instability by deactivation of control and regulatory mecha‐
nisms of cell apoptosis, cell cycle, and DNA repair [45, 46]. These mechanisms are essential for
the development of cervix carcinoma, once HPV prevalence in this type of cancer is 100% [48].
The same is true for oropharyngeal SCC, with a HPV prevalence up to 90% [49, 50]. In oral
SCC, the role of HPV still remains unclear. The anatomical structures of oropharynx, especially
the base of the tongue and tonsils, seem to be more susceptible to HPV infection when
compared to oral sites [34].
The prevalence of HPV in oral cancer may vary from 0 to 100% [51] and this may not be only
due to ethno-geographical differences but to the sensitivity of the applied diagnostic technique
and to the site of the lesion [51]. The first issue to study the HPV prevalence in these lesions is
the techniques employed to detect it. The most accurate ones seem to be the polymerase chain
reaction for the HPV DNA and in situ hybridization. The immunohistochemistry is also
employed but it can lose its accuracy in old specimens [52].
In well-designed studies selected in an elegant review of the literature on the role of HPV in
oral SCC, only nine split the groups between young and older people [5, 19, 53-59]. The
presence of high-risk HPV had a negative impact for the patient’s survival in four studies [5,
19, 55, 58], was neutral in three [53, 54, 59], and had a positive impact in only one investigation
[57]. Putting together all data, there is a clear need of more studies with larger samples and
more standardized methodology for the virus detection. Despite of the proved role of HPV in
the carcinogenesis of the cervix and oropharynx, it is still difficult to draw any conclusion
regarding the role of the high-risk HPV types 16 and 18 in the oral cancer development.




Most cases of oral SCC in young population occur at the mobile tongue. Treatment of tongue
tumors at any age depends on the clinical stage at diagnosis. Surgery and radiotherapy are the
standards of care for early-stage and also for locally advanced tumors in the oral cavity. The
specific treatment is dictated by the TN stage and, if N0 at diagnosis, by the risk of nodal
involvement [60]. For T1N0 tumors, surgical resection is recommended and no adjuvant
therapy is necessary. The T2 to T4 N0 tumors require local surgery and supraomohyoid neck
dissection. Treatment of the neck is expanded according to the worsening of cervical clinical
staging. Postoperative radiotherapy is indicated in the following cases: clinical stage III or IV,
presence of compromised or small surgical margins, presence of vascular or perineural
infiltration, presence of lymph node involvement or extracapsular spread [61]. At present,
there is no recommendation for a different approach on oral tumors in young patients [60].
Kaminagakura et al. [62] described a better overall survival in a group of young patients (<40-
year-old) treated after 1991, when compared to similar patients treated earlier. They attributed
this finding to the more aggressive and adequate treatment approaches applied and also to an
early diagnosis. So, does the treatment of oral SCC of young people need to be more aggressive?
This question can be answered only after understanding the evolution and prognosis of this
disease affecting young people. There is a suggestion that people under the age of 40 should
be treated differently from the older ones. This is based on the finding of high recurrence and
low survival rates between the young. [27]. Also, aggressive therapeutic approach for tongue
cancer was recommended by Myers et al. [20], with no age distinction. Controversially,
Goepfert et al. [6] described that young women (<45 years) with oral SCC had similar prognosis
when compared to older men and women with this disease, highlighting the unnecessary
adoption of adjuvant therapies in this particular group. Is it time to rethink the aggressive
treatments and the use of adjuvant unnecessary therapies [21]?
When over treatment occurs in young people, it may be motivated by emotional aspects
involving the diagnosis of a lethal condition in such a young person. Also, a radical option
may be influenced by the surgeon’s experience rather than by scientific evidence [6]. So, it is
of utmost importance to know if these tumors have worse prognosis to justify a more aggres‐
sive therapy.
6. Prognosis
The outcome for oral SCC occurring in youngsters is a major controversial issue. Various
studies have attempted to elucidate the prognostic significance of patient age at diagnosis.
Unfortunately, there are no prospective studies comparing elderly and younger patients
regarding prognosis. Also, there is no large multicentric research on this topic.
An ordinary question that can greatly affect the results of prognostic studies is the very
definition of what would be a young patient with oral SCC. This age limit is empirical and
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most studies use 40-year-old as the cutoff age [2, 4, 27, 29, 30, 63, 64]. Some outcome analyses
use the age of 30, 35, 45 [3, 5-8, 15, 28, 66] or even 60 years as the limit to be considered young
[67]. Pediatric patients with oral tumors (under 20 years) have also been studied [9]. So, if there
is not much consensus on the age of the patients to be considered young, it is quite difficult to
achieve consistent results, regarding the prognosis, when comparing these studies.
Some retrospective reports attempted to analyze prognosis for young population with oral
SCC, but they did not compare this data to older counterparts [20, 21, 23, 24, 68-76]. Mallet et
al. [68] found a high rate of persistent evolution and tumor recurrence within the first year
after treatment in a group of patients under 35-year-old, and this affected negatively the overall
survival. McGregor et al. [24] reported 80% cure rate among patients less than 40 years, but
similarly to Mallet et al. [68], patients who died from disease usually had a poor response to
initial treatment (within the first 2 years). Exceptionally good overall survival for patients < 40
years had been reported [20, 69]. These results suggest a good survival for young patients,
albeit with a subgroup of patients developing short term recurrence. The lack of comparison
with older counterparts weakened the results, regarding the role of age in prognosis.
The first comparative studies of oral SCC in young and old patients were published in 1998
by Siegelman-Danielli et al. [28] and Friedlander et al. [2]. They found similar outcome between
the groups. Subsequently, another 16 reports compared the evolution of young and older
patients with oral SCC, only 4 of them reporting worse prognosis. Analyzing these results, it
appears that age at diagnosis has no significance in the outcome for oral SCC.
A matched-pair analysis methodology was performed by some of these comparative reports
[2, 3, 5, 6, 15, 27, 62]. This design aims to match similar patients from 2 different groups (old
and young), often by sex and disease stage. So, when matched pairs are analyzed, the matched
variables are controlled, highlighting the patient’s age as an outcome predictor. Only one
matched pair analysis [27] showed worse prognosis for young oral cancer patients. This
literature is summarized on Table 1.
Although many authors recognized that early age at diagnosis is not an individual factor that
worsened outcome, some important information can be extracted from their results. In general,
more young patients have recurred locally and regionally [2, 4, 6, 22, 27, 29, 30, 62-64, 65]. This
finding may be explained by two theories: lack of adequate treatment and biologically different
behavior. Fang et al. [22] found 60% of local recurrence in young patients versus 11% among
the older ones, and both groups were treated similarly. Another study observed that most of
the recurrent young patients had been initially treated with radiotherapy and that this could
be the cause for the high recurrence rate [4]. In fact, the reason for inadequate treatment could
be explained by the intention to cause less morbidity because of the lower age. Aggressiveness
of the surgical procedure is difficult to compare, mainly because it suffers influence of
subjective factors during the surgical act and most of the studies had no information about the
margin size and status. However, because of the similar treatment approaches used in young
and old patients in most of the reports, it is possible that these tumors have a unique biological
behavior that needs to be well understood. Siegelmann-Danieli et al. [28] reported that tumors
developed in the absence of tobacco or alcohol occurred more frequently in young patients
and that patients at any age who developed disease without these risk factors may have a
worse outcome, reinforcing different pathological behavior.
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Authors Year Country Cases/controls Age limit* Study Design Outcome
Siegelmann-Danieli et al. 1998 USA 30/57 45 Non-matched Similar
Fredlander et al. 1998 USA 36/36 40 Matched-pairanalysis Similar
Pitman et al. 2000 USA 122/150 40 Non-matched Similar
Vargas et al. 2000 USA 17/17 40 Non-matched Worse(women)
Hyam et al. 2003 Australia 15/48/60 40 Non-matched Similar
Veness et al. 2003 Australia 22/142 40 Non-matched Similar
Popovtzer et al. 2004 Israel 16/32 45 Matched-pairanalysis Similar
Liao et al. 2006 Taiwan 76/220 40 Non-matched Similar
Siriwardena et al. 2007 Sri Lanka 56/56 40 Non-matched Similar/Undefined
Lee et al. 2007 Taiwan 20/20 45 Matched-pairanalysis Better
Garavelo et al. 2007 Italy 46/92 40 Matched-pairanalysis Worse
Ho et al. 2008 Taiwan 28/56 45 Matched-pairanalysis Better
Morris et al. 2010 USA 10/40 20 Non-matched Similar
Kaminagakura et al. 2010 Brazil 125/250 41 Matched-pairanalysis Similar
Park et al. 2010 Korea 23/62 45 Non-matched Worse
Soudry et al. 2010 Israel 11/74 30 Non-matched Similar
Hilly et al. 2013 Israel 16/62 30 Non-matched Worse whenrecurrent
Goepfert et al. 2014 USA 18/36 45 Matched-pairanalysis Similar
Fang et al. 2014 China 15/161 40 Non-matched Similar
*age limit for the young patient’s group.
Table 1. Literature review of comparative studies evaluating younger age as a predictor of outcome in oral SCC.
Another interesting fact is that young patients recurred earlier [3, 64] and a high percentage
of these recurrent young patients died of their disease [2, 3, 8, 22, 27]. A high index of recurrent
disease associated with fatality was observed in the reports of Friedlander et al. [2] and Hilly
et al. [8] (90% and 100%, respectively) and early fatality in 40% was reported by Popovtzer et
al. [3] (within the two first years).
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Moreover, there is some evidence that young patients developed more distant metastasis than
the older counterparts [7, 66]. No strong known predicting factors for distant metastasis was
found [65] and the observation of 100% incidence of death in distant failure patients indicated
that young patients more often present with more advanced disease and may have a distinct
pattern of recurrence [7]. Controversially, Fang et al. [22] observed 66% of locoregional
recurrence without a single distant metastasis in a group of young patients (n=15).
Some recognized microscopic adverse risk features for oral SCC are the extracapsular nodal
spread, positive margins, perineural invasion, and vascular embolism [60]. Unfortunately, there
is lack of information on microscopic status of the tumors in many reports [3, 5, 9, 63, 64, 66].
Perineural invasion was found to be similar between groups of young and old patients [7, 8].
Siegelmann-Danieli et al.[28] found similar extracapsular involvement in both groups, while
Hilly et al. [8] and Soudry et al. [7] found higher, but not significant, index of extracapsular spread
in young patients with nodal disease. There is evidence that cellular differentiation, depth of
tumor, nerve invasion and extracapsular spread of the involved lymph node were risk factors
for distant metastasis in young population with oral cancer. However, these characteristics were
not exclusive for young patients [65]. Studies failed to correlate extracapsular involvement,
differentiation and perineural invasion to worse outcome in the young [7, 8].
The correlation between the expression of Ki-67, cyclin D1, p16, PCNA, EGFR and angiogenesis
with outcome was investigated in young oral cancer population [31, 58, 69, 77, 78]. Overex‐
pression of Ki-67, a cell proliferation marker, was similar in both young and old patients.
Angiogenesis also had a similar rate [77]. Moreover, the high expression of cyclin D1 was an
indicator of worsened prognosis in both young and old groups [31]. P16 was a marker of
favorable prognosis among young population, although not a reliable predictor of HPV
presence [58]. A significantly increased number of mitosis, accompanied by strong PCNA
expression and higher number of metastasis in the older group were found by Siriwardena et
al. [78]. The authors believe that oral SCC in the older group is more proliferative, compared
with younger patients. Low levels of EGFR expression were associated with lower recurrence
rate in young patients, and those with high levels of expression had adverse prognosis [69].
Although there are microscopic factors recognizably influencing prognosis, the available
studies failed to demonstrate them in oral cancer affecting young population. These results
may be partially explained by the small groups analyzed. The immunoprofile of these tumors
are yet to be elucidated, and it appears to be a promising area of research.
A common limitation to all the comparative studies of oral cancer in young people is the small
population analyzed, since SCC of the oral cavity is a rare tumor. The largest group of young
patients in a single hospital was 125 people at Brazil, but unfortunately the high rates of T3
and T4 disease made this group quite different from the other ones [62]. Pitmann et al. [63]
studied 122 cases, but their population was not uniform, since 94 of these patients were
extracted from previous literature reports. The lower the cutoff age, the lower the sample size.
Morris et al. [9] and Soudry et al. [7] studied only 10 patients (< 20 years) and 11 patients (< 20
years), respectively.




Oral SCC in young people accounts for about 0.4–2.6% of the total incidence and has a slight
predominance in men. The most common location for this tumor is the tongue and occurrence
of symptoms is rare unless the lesion reaches a wide size. The delay before diagnosis varies
from few weeks to approximately 10 months.
Concerning the etiological factors for oral SCC in young adults who do not smoke and drink
alcohol frequently, genetic abnormalities seem to have a preponderant role in development of
the tumor. Additionally, human papilloma virus infection, specifically by HPV-16 and
HPV-18, are more frequently detected in this group, but more studies are needed to confirm
its influence in prognosis and clinical outcome of oral SCC in the younger.
In the light of current knowledge, it is possible to affirm that age is not an independent outcome
predictor for oral SCC. However, a group of young patients that develops a more aggressive
disease with a recurrent pattern seems to exist. In this group, early death is common. It is not
possible yet to point out the causes for this aggressive behavior. Supported by published
studies, treatment should be aggressive for both younger and older patients, and there is no
rationale for different approach in young population with oral SCC. Also, further multicentric
studies with standardized treatment protocols are necessary in order to elucidate the contro‐
versies of this fatal and increasing disease.
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